Home Search
cancer - search results
If you're not happy with the results, please do another search
AI breakthrough in cancer detection
AI model named Candycrunch has been designed to transform cancer detection through advanced sugar analysis.
Breaking barriers in breast cancer treatment: The shift towards personalised care
Dr Mark Verrill, Consultant Medical Oncologist at the Northern Centre for Cancer Care, discusses the importance of personalised breast cancer treatment.
From selfish silo to collaborative culture – embracing data-enabled cancer research
Aedin Culhane and Mark Lawler, Co-Leads of the eHealth Hub for Cancer, reflect on their data-enabled cancer research journeys, how their collaborative team science approach has reaped significant dividends in cancer research and policy and how the hub is inducing a paradigm shift in how health data are deployed on the island of Ireland.
Long waits for cancer care become routine across the UK
Long waits for cancer care have become normal across the UK, with nearly half of all specialist cancer centres experiencing delays most weeks, according to the Royal College of Radiologists (RCR).
Blood test predicts breast cancer recurrence years in advance
In a significant advancement for breast cancer treatment, a new blood test has shown the ability to predict the recurrence of breast cancer up to three years before tumours become detectable through conventional scans.
Personalized cancer medicines
Dr. Priya Hays, PhD, CEO and Science Writer at Hays Documentation Specialists, LLC, guides us through the world of personalized cancer medicines.
T cells successfully fighting cancer
Else Marit Inderberg and Sébastien Wälchli from Oslo University Hospital explore what we need to know about T cells successfully fighting cancer.
Altering cancer treatment dosing could significantly reduce its climate impact
The University of Michigan Health Rogel Cancer Center has revealed that changing the dosing schedule for common cancer therapy could greatly reduce greenhouse gas emissions without compromising the patient's outcomes.
Can obesity cause cancer? Examining the connection between obesity and cancer
63.8% of the UK population are currently overweight or obese. Obesity is a major cause of ill health. Being moderately obese takes around 3 years off your life, whereas severe obesity shortens it by at least 10 years.
New target to combat chemotherapy resistance in deadly brain cancer
For patients battling glioblastoma, a highly aggressive and deadly form of brain cancer, resistance to chemotherapy remains a significant obstacle.
Oxford Study finds blood proteins could predict cancer risk years in advance
Researchers from Oxford Population Health's Cancer Epidemiology Unit have identified specific proteins in the blood that may predict a person's risk of developing various cancers over seven years before diagnosis.
Plant virus-based treatment effective against metastatic cancer
In a recent study, researchers at the University of California San Diego have developed an experimental treatment made from a plant virus that shows effectiveness in protecting against a broad range of metastatic cancers in mice.
Lung cancer in Southeast Asia and China: Current trends and challenges
Zisis Kozlakidis from the World Health Organization’s International Agency for Cancer and Jiaao Yu from the Shanghai Jiao Tong University discuss the burden of lung cancer in Southeast Asia and China and the priorities for therapies and interventions.
Key pathway in cancer cell growth
Researchers from Johns Hopkins Medicine have revealed a crucial molecular pathway that drives cells toward uncontrolled genome duplication.
Assessing blood clot risk in venous catheter selection for patients with haematological cancers
Venous catheters enable patients with haematological cancers to receive vital chemotherapy. However, there is a risk of thrombosis. Consultant Haematologist Priya Sriskandarajah analysed a group of patients with haematological cancers to study the implications of catheter selection.
Collaboration and Partnerships in Accelerating Cancer Drug Development
Lorna Rothery spoke to the Cancer Drug Development Forum’s Managing Director, Professor Jaap Verweij and Chairperson of the CDDF Board of Directors, Professor Ruth Plummer, about opportunities and challenges in oncology research and treatment.
Professor Jaap Verweij – Cancer Drug Development Forum (CDDF)
Jaap Verweij, M.D., Ph.D is an Emeritus Professor of Medical Oncology, and former Dean of the Faculty of Medicine at Erasmus University Medical Centre
He served as chair of the Department of Medical Oncology, and chair of the Daniel den Hoed Cancer Center at the Erasmus University Medical Centre from...
Professor Ruth Plummer – Cancer Drug Development Forum (CDDF)
Ruth Plummer is a Professor of Experimental Cancer Medicine in the Translational and Clinical Research Institute, Newcastle University, and an honorary consultant medical oncologist in Newcastle Hospitals NHS Foundation Trust.
Prof. Plummer is director of the Sir Bobby Robson Cancer Trials Research Centre within the Northern Centre for Cancer Care....
Liver inflammation’s role in cancer treatment resistance
Is the a link between liver inflammation and cancer treatment outcomes? Researchers have found why certain cancers become resistant to immunotherapy.